University of California San Francisco

Rural-Urban Differences in Sun Exposure and Protection Behaviors in the United States.

Dona AC, Jewett PI, Henning-Smith C, Ahmed RL, Wei ML, Lazovich D, Vogel RI PMID: 38227023

Recurrent inverse necrotizing infundibular crystalline folliculitis.

Ibraheim MK, Storey L, North JP PMID: 38563487

International Time Trends and Differences in Topical Actinic Keratosis Therapy Utilization.

Heather J. Zhao, Inna Ushcatz, Mina Tadrous, Valeria Aoki, Aileen Y. Chang, Nick J. Levell, Lena Von Schuckmann, Aaron M. Drucker PMID:

Functional and Cutaneous Treatment Outcomes With Intravenous Immunoglobulin for Eosinophilic Fasciitis: A Retrospective Study.

Obiakor B, Fan W, Jacobson R, Gandelman J, Haemel A PMID: 38564381

The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response.

Bui A, Orcales F, Kranyak A, Chung BY, Haran K, Smith P, Johnson C, Liao W PMID: 38796275

Psychiatric comorbidities associated with rosacea: a propensity score-matched case-control study in the All of Us database.

Abdi P, Haq Z, Diaz MJ, Maibach HI PMID: 38011317

Artificial intelligence and skin cancer.

Wei ML, Tada M, So A, Torres R PMID: 38566925

Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis.

James WA, Rosenberg AL, Wu JJ, Hsu S, Armstrong A, Wallace EB, Lee LW, Merola J, Schwartzman S, Gladman D, Liu C, Koo J, Hawkes JE, Reddy S, Prussick R, Yamauchi P, Lewitt M, Soung J, Weinberg J, Lebwohl M, Glick B, Kircik L, Desai S, Feldman SR, Zaino ML PMID: 38499181

Atopic dermatitis, cognitive function and psychiatric comorbidities across early childhood and adolescence in a population-based UK birth cohort.

Sockler PG, Hooper SR, Abuabara K, Ma EZ, Radtke S, Bao A, Kim E, Musci RJ, Kartawira K, Wan J PMID: 38060978

Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'.

Johnson C, Smith P, Haran K, Kranyak A, Liao W, Bhutani T PMID: 38149911